Less than a week after Health Canada removed limits on how much pot it could produce, Gatineau-based Hydropothecary (TSX-V:THCX) says it’s raising $20 million in new financing.
The firm said Tuesday that it had entered into an agreement with its longtime financing partner, Canaccord Genuity Corp., and a syndicate of underwriters to raise the money via a private placement.
Last week, Health Canada approved two new buildings at Hydropothecary’s Gatineau facilities and granted the pot producer a licence renewal to grow and sell as much cannabis as it can store.
OBJ360 (Sponsored)
![People enjoying the Ottawa REDBLACKS Subaru log cabin](https://assets.obj.ca/2024/06/subaru-log-cabin-2023-gallery-300x169.gif)
Game on! How Ottawa REDBLACKS business experiences create meaningful connections
An Ottawa REDBLACKS game may be the only place a business leader should leave their game face at the door.
![Queensway Carleton Hospital Lumiere fundraiser](https://assets.obj.ca/2024/06/Lumiere_20240628_135436_0000-300x169.jpg)
Get ready to ROCK! The Lumière Gala returns to the Brookstreet this September
Brookstreet has always been a rock star in the world of hospitality. Now, the hotel is truly embracing the rock and roll vibe with this year’s themed gala in support
A Hydropothecary spokesperson said Tuesday that the loosened restrictions signal a major move on the part of Health Canada to fast-track industry expansion ahead of the federal government’s plans to legalize marijuana for recreational use by July 2018.
The move came as Ontario Finance Minister Charles Sousa was quoted as saying that he expects a shortage of marijuana when it’s legalized, echoing previous comments by financial analysts.
Hydropothecary’s stock price was down 9.5 per cent, or 15 cents per share, to $1.43 in late-afternoon trading on the TSX Venture Exchange.